Gennadiy Zelinskyy

6PUBLICATIONS
44CO-AUTHORS
Disease surveillanceMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 06, 2026
Dendritic cell-specific hypoxia-inducible factor-1α deficiency protects mice from recurrent retroviral infection.

|May 18, 2023
HLA Class II Loss and JAK1/2 Deficiency Coevolve in Melanoma Leading to CD4 T-cell and IFNγ Cross-Resistance.

Simone Stupia, Christina Heeke, Alicia Brüggemann

|Apr 01, 2020
Combination immunotherapy with anti-PD-L1 antibody and depletion of regulatory T cells during acute viral infections results in improved virus control but lethal immunopathology.

Paul David, Malgorzata Drabczyk-Pluta, Eva Pastille

|Feb 24, 2020
Critical role of PD-L1 expression on non-tumor cells rather than on tumor cells for effective anti-PD-L1 immunotherapy in a transplantable mouse hematopoietic tumor model.

Jose-Ignacio Rodriguez-Barbosa, Miyuki Azuma, Gennadiy Zelinskyy

|Dec 21, 2018
MDSCs in infectious diseases: regulation, roles, and readjustment.

Anca Dorhoi, Estibaliz Glaría, Thalia Garcia-Tellez

|Aug 25, 2017
Granulocytic myeloid-derived suppressor cells suppress virus-specific CD8+ T cell responses during acute Friend retrovirus infection.

Malgorzata Drabczyk-Pluta, Tanja Werner, Daniel Hoffmann

Pageof 1

Frequent Collaborators

2 joint publications

Ulf Dittmer

2 joint publications

Dirk Schadendorf

2 joint publications

Mirko Trilling

1 joint publications

Sandra Winning